GLP-1, secreted by ileal L-cells, promotes insulin release, but its action is notably diminished in patients.[45] Changes in the gut environment of patients with IBD, including inflammation, altered secretion of gut hormones, and impaired absorption, collectively influence the effects of incretin. This evidence concerns the gene GCG and inflammatory bowel disease.